Tudor Investment Corp
TVRD

Tudor Investment Corp’s Tvardi Therapeutics TVRD Stock Holding History

Tudor Investment Corp’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,587
Closed -$28.7K – 3604
2024
Q3 		$28.7K Hold
2,587
– – ﹤0.01% 2627
2024
Q2 		$24K Hold
2,587
– – ﹤0.01% 2245
2024
Q1 		$84.7K Hold
2,587
– – ﹤0.01% 2101
2023
Q4 		$69.2K Hold
2,587
– – ﹤0.01% 2259
2023
Q3 		$156K Sell
2,587
-2,718
-51% -$255K ﹤0.01% 2117
2023
Q2 		$540K Buy
5,305
+1,599
+43% +$220K 0.01% 1671
2023
Q1 		$655K Buy
+3,706
New +$1.24M 0.01% 1453
2022
Q4 		– Sell
-3,711
Closed -$1.25M – 2933
2022
Q3 		$1.25M Buy
3,711
+1,067
+40% +$386K 0.03% 779
2022
Q2 		$869K Buy
+2,644
New +$928K 0.02% 968
2021
Q3 		– Sell
-2,014
Closed -$1.03M – 2876
2021
Q2 		$1.03M Buy
+2,014
New +$1.28M 0.02% 851
2020
Q4 		– Sell
-602
Closed -$276K – 1677
2020
Q3 		$276K Buy
+602
New +$350K 0.01% 1014
2017
Q2 		– Sell
-2,045
Closed -$1.35M – 1426
2017
Q1 		$1.35M Buy
+2,045
New +$1.09M 0.04% 274
2016
Q4 		– Sell
-346
Closed -$104K – 1645
2016
Q3 		$104K Sell
346
-897
-72% -$194K ﹤0.01% 1336
2016
Q2 		$215K Sell
1,243
-976
-44% -$212K ﹤0.01% 1369
2016
Q1 		$497K Buy
2,219
+1,887
+568% +$564K 0.01% 945
2015
Q4 		$202K Sell
332
-101
-23% -$55.5K 0.01% 1438
2015
Q3 		$223K Buy
+433
New +$290K 0.01% 1275

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tudor Investment Corp's TVRD Position: Q4 2024 in Review

Tudor Investment Corp sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 2,587 shares — an estimated $28.7K sold.

Tudor Investment Corp first reported a position in TVRD in Q3 2015 and held it in 17 quarters. The position peaked at $1.35M in Q1 2017. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

  • Tudor Investment Corp reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 2,587 Tvardi Therapeutics shares in Q4 2024, an estimated $28.7K.
  • Tudor Investment Corp first reported a position in Tvardi Therapeutics in Q3 2015 and held it in 17 quarters.
  • Tudor Investment Corp's Tvardi Therapeutics position peaked at $1.35M in Q1 2017.
  • 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.